---
schema_version: "secwatch.filing_event.v1"
accession: "0000716643-21-000096"
form_type: "8-K"
ticker: "RGS"
cik: "0000716643"
company_name: "REGIS CORP"
filed_at: "2021-12-23T23:59:59+00:00"
generated_at: "2026-06-27T22:44:57.361741+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Regis CEO Felipe Athayde resigns; Matt Doctor named Interim CEO

## Summary
- Felipe Athayde resigns as President and CEO, effective March 19, 2022; remains on Board until then.
- Matthew Doctor appointed Interim CEO effective Dec 23, 2021; base salary raised to $550,000, target 100% incentive, plus $100,000 acceptance bonus.
- Jim Lain appointed COO effective Dec 23, 2021; base salary raised to $425,000, target annual incentive remains at 70%.
- Board commences search for permanent CEO, considering internal and external candidates.
- Michael Ferranti promoted to Executive Vice President and Chief People Officer.

## SEC filing metadata
- accession: 0000716643-21-000096
- form_type: 8-K
- ticker: RGS
- cik: 0000716643
- company_name: REGIS CORP
- filed_at: 2021-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/716643/000071664321000096/0000716643-21-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/716643/000071664321000096/rgs-20211219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000716643-21-000096
- JSON: https://secwatch.observer/filing/0000716643-21-000096.json
- Plain text: https://secwatch.observer/filing/0000716643-21-000096.txt

## Key facts
- Executive change
  Felipe A. Athayde resigned as President and Chief Executive Officer at REGIS CORP.
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: On December 19, 2021, Felipe A. Athayde, the President and Chief Executive Officer and a member of the Board of Directors (the "Board") of Regis Corporation (the "Company") notified the Board that he would resign his positions and his employment effective March 19, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/716643/000071664321000096/0000716643-21-000096-index.htm
- Executive change
  Matthew Doctor was appointed as Interim Chief Executive Officer at REGIS CORP.
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: the Board appointed Matthew Doctor, the Company's Executive Vice President and Chief Strategy Officer, to serve as Interim Chief Executive Officer effective December 23, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/716643/000071664321000096/0000716643-21-000096-index.htm
- Executive change
  Jim Lain was appointed as Chief Operating Officer at REGIS CORP.
  - Action: appointed
  - Role: Chief Operating Officer
  source text: the Board appointed Jim Lain, the Company's President, Franchise Operations, who functions as the Company's principal operating officer, to the position of Chief Operating Officer of the Company, also effective December 23, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/716643/000071664321000096/0000716643-21-000096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.